In addition to the pituitary tumour cell and immune cell-derived angiogenic compounds, secreted proteins from pituitary tumour-associated fibroblasts, namely CCL2 as previously shown [10], may further contribute for PitNET angiogenesis, as described in other cancers [15, 64, 65]. The gene discussed is CCL2; the disease is cancer.